Oral treatment may not be far off for head and neck cancer patients 

Features
Published
A highly promising approach to treating HPV-drivenhead andneckcanceris on the way,and it could be in the shape of a simple oral medication. This isaccording tonewbreakthroughresearch led by Griffith University, whichhas conductedtrials showingthat the drug, Alisertib, testedin trialsto treat other cancers such as lung and kidney,can alsosuccessfullydestroy the cancer cellsassociated withhead andneckcancer. Human Papilloma Virus (HPV) […]